BioPharmaceutical Business Intelligence

  • Analyze global market entry opportunities
  • Uncover prior art in expired and abandoned patents
  • Drug patents in 130+ countries
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
Chubb
Mallinckrodt
US Army
Medtronic
Johnson and Johnson
Accenture
US Department of Justice
AstraZeneca
McKesson

Generated: January 24, 2018

DrugPatentWatch Database Preview

SOMATROPIN RECOMBINANT - Generic Drug Details

« Back to Dashboard

What are the generic drug sources for somatropin recombinant and what is the scope of somatropin recombinant patent protection?

Somatropin recombinant
is the generic ingredient in twenty branded drugs marketed by Emergent, Ferring, Pharmacia And Upjohn, Lilly, Novo Nordisk Inc, Genentech, Sandoz, Emd Serono, and Lg Chem Ltd, and is included in fourteen NDAs. There are seventeen patents protecting this compound. Additional information is available in the individual branded drug profile pages.

Somatropin recombinant has two hundred and fifteen patent family members in twenty-eight countries.

There are four drug master file entries for somatropin recombinant. Eight suppliers are listed for this compound.
Summary for SOMATROPIN RECOMBINANT
Pharmacology for SOMATROPIN RECOMBINANT

US Patents and Regulatory Information for SOMATROPIN RECOMBINANT

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Novo Nordisk Inc NORDITROPIN somatropin recombinant INJECTABLE;INJECTION 021148-003 Jun 20, 2000 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Novo Nordisk Inc NORDITROPIN NORDIFLEX somatropin recombinant INJECTABLE;INJECTION 021148-006 Oct 1, 2004 DISCN No No ➤ Subscribe ➤ Subscribe Y ➤ Subscribe
Emd Serono ZORBTIVE somatropin recombinant INJECTABLE;INJECTION 021597-003 Dec 1, 2003 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Genentech NUTROPIN DEPOT somatropin recombinant INJECTABLE;INJECTION 021075-003 Dec 22, 1999 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Novo Nordisk Inc NORDITROPIN FLEXPRO somatropin recombinant INJECTABLE;INJECTION 021148-009 Mar 1, 2010 BX RX No No ➤ Subscribe ➤ Subscribe Y ➤ Subscribe
Novo Nordisk Inc NORDITROPIN somatropin recombinant INJECTABLE;INJECTION 019721-001 May 8, 1995 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Emd Serono SAIZEN somatropin recombinant INJECTABLE;INJECTION 019764-001 Oct 8, 1996 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Pharmacia And Upjohn GENOTROPIN PRESERVATIVE FREE somatropin recombinant INJECTABLE;INJECTION 020280-010 Jan 27, 1998 RX Yes No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Lilly HUMATROPE somatropin recombinant INJECTABLE;INJECTION 019640-004 Mar 8, 1987 BX RX Yes Yes ➤ Subscribe ➤ Subscribe ➤ Subscribe
Novo Nordisk Inc NORDITROPIN NORDIFLEX somatropin recombinant INJECTABLE;INJECTION 021148-006 Oct 1, 2004 DISCN No No ➤ Subscribe ➤ Subscribe Y ➤ Subscribe
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Expired US Patents for SOMATROPIN RECOMBINANT

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Pharmacia And Upjohn GENOTROPIN PRESERVATIVE FREE somatropin recombinant INJECTABLE;INJECTION 020280-004 Aug 24, 1995 ➤ Subscribe ➤ Subscribe
Novo Nordisk Inc NORDITROPIN FLEXPRO somatropin recombinant INJECTABLE;INJECTION 021148-011 Jan 23, 2015 ➤ Subscribe ➤ Subscribe
Pharmacia And Upjohn GENOTROPIN PRESERVATIVE FREE somatropin recombinant INJECTABLE;INJECTION 020280-010 Jan 27, 1998 ➤ Subscribe ➤ Subscribe
Pharmacia And Upjohn GENOTROPIN PRESERVATIVE FREE somatropin recombinant INJECTABLE;INJECTION 020280-005 Jan 27, 1998 ➤ Subscribe ➤ Subscribe
Pharmacia And Upjohn GENOTROPIN PRESERVATIVE FREE somatropin recombinant INJECTABLE;INJECTION 020280-002 Jan 27, 1998 ➤ Subscribe ➤ Subscribe
Pharmacia And Upjohn GENOTROPIN PRESERVATIVE FREE somatropin recombinant INJECTABLE;INJECTION 020280-003 Jan 27, 1998 ➤ Subscribe ➤ Subscribe
Novo Nordisk Inc NORDITROPIN NORDIFLEX somatropin recombinant INJECTABLE;INJECTION 021148-004 Oct 1, 2004 ➤ Subscribe ➤ Subscribe
Lilly HUMATROPE somatropin recombinant INJECTABLE;INJECTION 019640-007 Feb 4, 1999 ➤ Subscribe ➤ Subscribe
Novo Nordisk Inc NORDITROPIN FLEXPRO somatropin recombinant INJECTABLE;INJECTION 021148-010 Mar 1, 2010 ➤ Subscribe ➤ Subscribe
Novo Nordisk Inc NORDITROPIN somatropin recombinant INJECTABLE;INJECTION 021148-003 Jun 20, 2000 ➤ Subscribe ➤ Subscribe
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Non-Orange Book US Patents for SOMATROPIN RECOMBINANT

For Orange Book-listed patents (shown in the main table above) generic applications must certify that the listed patents are expired, invalid, or will not be infringed by generic entry.

The non-Orange Book patents listed below do not require formal certifications, so they do not automatically impede generic entry. Instead, they represent potential opportunities for branded firms to block generic entry through patent infringment challenges.

Patent No. Title Estimated Patent Expiration
8,357,120 Injection device with torsion spring and rotatable display ➤ Subscribe
6,582,404 Dose setting limiter ➤ Subscribe
9,616,180 Automatic injection device with a top release mechanism ➤ Subscribe
7,686,786 Dial-down mechanism for wind-up pen ➤ Subscribe
8,096,978 Automatic injection device with a top release mechanism ➤ Subscribe
Patent No. Title Estimated Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

International Patents for SOMATROPIN RECOMBINANT

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Merck
Covington
Accenture
Moodys
Teva
Deloitte
Dow
Fuji
Cerilliant

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot